SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012838
Filing Date
2020-11-05
Accepted
2020-11-05 16:05:02
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20200930x10q.htm   iXBRL 10-Q 2437167
2 EX-10.1 rigl-20200930xex10d1.htm EX-10.1 14806
3 EX-31.1 rigl-20200930xex31d1.htm EX-31.1 16319
4 EX-31.2 rigl-20200930xex31d2.htm EX-31.2 16970
5 EX-32.1 rigl-20200930xex32d1.htm EX-32.1 8804
6 GRAPHIC rigl-20200930x10q004.jpg GRAPHIC 78528
  Complete submission text file 0001558370-20-012838.txt   8372596

Data Files

Seq Description Document Type Size
7 EX-101.SCH rigl-20200930.xsd EX-101.SCH 51116
8 EX-101.CAL rigl-20200930_cal.xml EX-101.CAL 50305
9 EX-101.DEF rigl-20200930_def.xml EX-101.DEF 171053
10 EX-101.LAB rigl-20200930_lab.xml EX-101.LAB 459783
11 EX-101.PRE rigl-20200930_pre.xml EX-101.PRE 313638
12 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20200930x10q_htm.xml XML 1571738
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 201290392
SIC: 2834 Pharmaceutical Preparations